Read + Share
Amedeo Smart
Independent Medical Education
Khan SU, Yedlapati SH, Lone AN, Hao Q, et al. PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis. BMJ 2022;377:e069116.PMID: 35508321
Email
LinkedIn
Facebook
Twitter
Privacy Policy